Patents by Inventor Antonio J. Grillo-Lopez

Antonio J. Grillo-Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
    Patent number: 10400043
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: September 3, 2019
    Assignee: Biogen, Inc.
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
    Patent number: 10113000
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: October 30, 2018
    Assignee: Biogen Inc.
    Inventor: Antonio J. Grillo-Lopez
  • TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20180264107
    Abstract: The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.
    Type: Application
    Filed: May 17, 2018
    Publication date: September 20, 2018
    Applicants: Genentech, Inc., Biogen Inc.
    Inventors: John G. Curd, Antonio J. Grillo-Lopez, Lori A. Kunkel
  • Treatment of pemphigus
    Patent number: 9993550
    Abstract: The present invention concerns treatment of pemphigus with an antibody which binds to CD20.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: June 12, 2018
    Assignees: Genentech, Inc., Biogen Idec Inc.
    Inventors: John G. Curd, Antonio J. Grillo-Lopez
  • TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
    Publication number: 20180118844
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 3, 2018
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
    Publication number: 20170037139
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Application
    Filed: October 25, 2016
    Publication date: February 9, 2017
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
    Publication number: 20170037140
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Application
    Filed: October 25, 2016
    Publication date: February 9, 2017
    Inventor: Antonio J. Grillo-Lopez
  • Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
    Patent number: 9504744
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: November 29, 2016
    Assignee: Biogen Inc.
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
    Publication number: 20160333106
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Application
    Filed: August 1, 2016
    Publication date: November 17, 2016
    Inventor: Antonio J. Grillo-Lopez
  • TREATMENT OF PEMPHIGUS
    Publication number: 20160175435
    Abstract: The present invention concerns treatment of pemphigus with an antibody which binds to CD20.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 23, 2016
    Applicants: BIOGEN INC., GENENTECH, INC.
    Inventors: John G. Curd, Antonio J. Grillo-Lopez
  • Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
    Patent number: 9296821
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: March 29, 2016
    Assignee: Biogen Inc.
    Inventor: Antonio J. Grillo-López
  • COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
    Publication number: 20150183882
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Application
    Filed: March 11, 2015
    Publication date: July 2, 2015
    Applicant: Biogen Idec, Inc.
    Inventor: Antonio J. GRILLO-LOPEZ
  • USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
    Publication number: 20140363424
    Abstract: The use of anti-CD20 antibodies as in vivo purging agents for patients receiving bone marrow or peripheral blood stem cell transplant during treatment of B-cell-related diseases, e.g., B-cell lymphomas or leukemias, is disclosed. Such purging may enhance engraftment and/or prevent disease relapse in such patients.
    Type: Application
    Filed: January 14, 2014
    Publication date: December 11, 2014
    Applicant: Biogen Idec Inc.
    Inventors: Antonio J. Grillo-Lopez, John Leonard
  • TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
    Publication number: 20140302018
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Application
    Filed: June 20, 2014
    Publication date: October 9, 2014
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
    Patent number: 8821873
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: September 2, 2014
    Assignee: Biogen Idec Inc.
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20140134164
    Abstract: The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicants: BIOGEN IDEC INC., GENENTECH, INC.
    Inventors: John G. Curd, Lori A. Kunkel, Antonio J. Grillo-Lopez
  • COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
    Publication number: 20140056887
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Application
    Filed: November 1, 2013
    Publication date: February 27, 2014
    Applicant: Biogen Idec Inc.
    Inventor: Antonio J. Grillo-Lopez
  • TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
    Publication number: 20140030263
    Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 30, 2014
    Applicant: Biogen Idec Inc.
    Inventors: Christine A. White, Antonio J. Grillo-Lopez
  • TREATMENT OF PEMPHIGUS
    Publication number: 20130330332
    Abstract: The present invention concerns treatment of pemphigus with an antibody which binds to CD20.
    Type: Application
    Filed: August 16, 2013
    Publication date: December 12, 2013
    Applicants: Biogen Idec Inc., Genentech, Inc.
    Inventors: John G. Curd, Antonio J. Grillo-Lopez
  • COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
    Publication number: 20130273039
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
    Type: Application
    Filed: April 23, 2013
    Publication date: October 17, 2013
    Inventor: Antonio J. Grillo-Lopez